Steve Goldy Email

VP Sales and Marketing, Americas . Anika Therapeutics

Current Roles

Employees:
456
Revenue:
$144.7M
About
Headquartered in Woburn, Mass., Anika Therapeutics, Inc. (www.anikatherapeutics.com) develops, manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. In addition to ORTHOVISC(R), a treatment for osteoarthritis of the knee (not approved for sale in the U.S.), Anika markets HYVISC(R) in the U.S. for the treatment of equine osteoarthritis through Boehringer Ingelheim Vetmedica, Inc. and manufactures AMVISC(R) and AMVISC(R) Plus, HA viscoelastic products for ophthalmic surgery, for Bausch & Lomb. It also produces STAARVISCTM-II for distribution by STAAR Surgical Company, Shellgel(TM) for Cytosol Ophthalmics, Inc., and CoEase(TM) for Allergan, Inc.
Anika Therapeutics Address
1813 Sheldon Ave
Bedford, MA
United States

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.